Skip to main content
SpringerLink
Log in

Removing Prescription Charges for Patients with Mental Health Disorders

Would it Improve Patient Outcomes in the UK?

  • Current Opinion
  • Published:
Disease Management & Health Outcomes

Abstract

The cost of copayments can deter patients from complying with essential medication. This can have a detrimental effect on health outcome and consequently healthcare costs. People with mental illness are commonly treated with regular and effective medication and are one group that is potentially vulnerable to these negative effects of copayments on compliance. Despite the existence of prescription charge exemptions in the UK, mental health disorders do not qualify for free prescriptions under the current list of chronic medical conditions. It has therefore been advocated by some that people with long-term mental health problems should receive exemption from prescription charges. Indeed, the existing evidence suggests that free medication would improve access, compliance and, consequently, health outcomes, which is also likely to result in savings of healthcare expenditure. However, simply adding mental health disorders to the list of chronic conditions qualifying for prescription charge exemption may not be the most appropriate way of achieving this. Despite alleviating the economic burden of people with mental health problems, such a move would leave other, equally deserving, chronic conditions excluded and would perpetuate the inequity of the current prescription charge exemptions. This article therefore suggests the need for a much more in-depth review of UK prescription charges and exemptions. It discusses possible ways of protecting vulnerable population groups against problems of medication cost and affordability, whilst taking the issue of limited National Health Service resources into account.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I

Similar content being viewed by others

Notes

  1. 1 This concept is complicated by the fact that it is the prescriber, rather than the patient, who makes a decision or choice of what medication is required. Thus, it is questionable if patients can, and should be expected to, make rational (cost-related) decisions on what medication is required, when the decision is not entirely theirs and they don’t actually hold all of the necessary information to make such a decision.

  2. In Wales, PPCs currently cost £15.69 ($US27.45, ₠22.75; conversion in 2006) for 4 months and £43.09 ($US75.35, ₠62.40; conversion in 2006) for 12 months.

References

  1. Mind. The hidden costs of mental health. London (UK): Mind, 2003

    Google Scholar 

  2. World Health Organization. The world health report 2001 — mental health: new understanding, new hope [online]. Geneva (Switzerland): World Health Organization, 2001. Available from URL: http://www.who.int/whr/2001/en/index.html [Accessed 2006 Feb 21]

    Google Scholar 

  3. Huttin C. The use of prescription charges. Health Policy 1994; 2: 53–73

    Article  Google Scholar 

  4. Lexchin J, Grootendorst P. Effects of prescription drug user fees on drug and health services use and on health status in vulnerable populations: a systematic review of the evidence. Int J Health Serv 2004; 34: 101–22

    Article  PubMed  Google Scholar 

  5. Stuart B, Grana J. Ability to pay and the decision to medicate. Med Care 1998; 36: 202–11

    Article  PubMed  CAS  Google Scholar 

  6. Tamblyn R, Laprise R, Hanley JA, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA 2001; 285: 421–9

    Article  PubMed  CAS  Google Scholar 

  7. O’Brien B. The effect of patient charges on the utilisation of prescription medicines. J Health Econ 1989; 8: 109–32

    Article  PubMed  Google Scholar 

  8. Ryan M, Birch S. Charging for health care: evidence on the utilisation of NHS prescribed drugs. Soc Sci Med 1991; 33: 681–7

    Article  PubMed  CAS  Google Scholar 

  9. Hughes D, McGuire A. Patient charges and the utilisation of NHS prescription medicines: some estimates using a cointegration procedure. Health Econ 1995; 4: 213–20

    Article  PubMed  CAS  Google Scholar 

  10. Rice T, Matsuoka KY. The impact of cost-sharing on appropriate utilization and health status: a review of the literature on seniors. Med Care Res Rev 2004; 61: 415–52

    Article  PubMed  Google Scholar 

  11. Beardon PHG, McGilchrist MM, McKendrick AD, et al. Primary non-compliance with prescribed medication in primary care. BMJ 1993; 307: 846–8

    Article  PubMed  CAS  Google Scholar 

  12. Jones I, Britten N. Why do some patients not cash their prescriptions? Br J Gen Pract 1998; 48: 903–5

    PubMed  CAS  Google Scholar 

  13. Schafheutle EI, Hassell K, Seston EM, et al. Non-dispensing of NHS prescriptions in community pharmacies. Int J Pharm Pract 2002; 10: 11–5

    Article  Google Scholar 

  14. Schafheutle EI, Hassell K, Noyce PR, et al. Access to medicines: cost as an influence on the views and behaviour of patients. Health Soc Care Community 2002; 10: 187–95

    Article  PubMed  Google Scholar 

  15. Schafheutle EI, Hassell K, Noyce PR. Coping with prescription charges in the UK. Int J Pharm Pract 2004; 12: 239–46

    Article  Google Scholar 

  16. Atella V, Schafheutle E, Noyce P, et al. Affordability of medicines and patients’ cost reduction behaviors: empirical evidence based on SUR estimates from Italy and the UK. Appl Health Econ Health Policy 2005; 4(1): 23–35

    Article  PubMed  Google Scholar 

  17. Doran E, Robertson J, Rolfe I, et al. Patient co-payments and use of prescription medicines. Aust N Z J Public Health 2004; 28(1): 62–7

    Article  PubMed  Google Scholar 

  18. Cox ER, Jernigan C, Joel Coons SJ, et al. Medicare beneficiaries’ management of capped prescription benefits. Med Care 2001; 39: 296–301

    Article  PubMed  CAS  Google Scholar 

  19. Schafheutle E. Do high prescription charges undermine compliance? Pharmaceutical J 2003; 270: 336–7

    Google Scholar 

  20. Schafheutle E. The prescription charge: a barrier to treatment [editorial]. Prescriber 2003; 14(11): 10–3

    Google Scholar 

  21. Gowrisankaran G, Town RJ. Managed care, drug benefits and mortality: an analysis of the elderly [online]. St Louis (MO): Olin School of Business, 2005. Available from URL: http://www.olin.wustl.edu/faculty/gowrisankaran/pdf_papers/Medicare_managed_care.pdf [Accessed 2006 Feb 21]

    Google Scholar 

  22. Lundberg L, Johannesson M, Isacson DGL, et al. Effects of user charges on the use of prescription medicines in different socio-economic groups. Health Policy 1998; 44: 123–34

    Article  PubMed  CAS  Google Scholar 

  23. Safran DG, Neuman P, Schoen C, et al. Prescription drug coverage and seniors: findings from a 2003 national survey. Health Affairs Web Exclusive 2005 (Apr); W5: 152–66

    Google Scholar 

  24. Wanless D. Securing our future health: taking a long-term view. An interim report [online]. London (UK): HM Treasury, 2001. Available from URL: http://www.hm-treasury.gov.uk/consultations_and_legislation/wanless/consult_wanless_interimrep.cfm [Accessed 2006 Feb 21]

    Google Scholar 

  25. Department of Health. NHS costs and exemptions [online]. London (UK): Department of Health, 2005. Available from URL: http://www.dh.gov.uk/Policy-AndGuidance/MedicinesPharmacyAndIndustry/Prescriptions/NHSCosts/fs/en [Accessed 2006 Feb 21]

    Google Scholar 

  26. National Health Service. HC11: help with health costs [online]. London (UK): Department of Health, 2004. Available from URL: http://www.dh.gov.uk/assetRoot/04/12/18/31/04121831.pdf [Accessed 2006 Feb 21]

    Google Scholar 

  27. Sihota SK. Creeping charges: NHS prescription, dental & optical charges. An urgent case for treatment [online]. London (UK): National Consumer Council, 2003. Available from URL: http://www.ncc.org.uk/health/creeping_charges.pdf [Accessed 2006 Feb 21]

    Google Scholar 

  28. Social Market Foundation. A fairer prescription for NHS charges: Health Commission — report 1 [online]. London (UK): Social Market Foundation, 2003. Available from URL: http://www.smf.co.uk/index.php?.name=UpDownload&req=getit&lid=99 [Accessed 2006 Feb 21]

    Google Scholar 

  29. Phelps L. Unhealthy charges: CAB evidence on the impact of charges for NHS treatment [online]. London (UK): National Association of Citizens Advice Bureaux, 2001. Available from URL: http://www.citizensadvice.org.uk/index/campaigns/social_policy/evidence_reports/er_healthcomcare/unhealthycharges [Accessed 2006 Feb 21]

    Google Scholar 

  30. British Medical Association. Funding: prescription charges [online]. London (UK): British Medical Association, 2005. Available from URL: http://www.b-ma.org.uk/ap.nsf/Content/FundingPrescriptionCharges [Accessed 2006 Feb 21]

    Google Scholar 

  31. National Pharmacy Association. Pharmacists condemn prescription charges increase — and call for a total review of the system [online]. St Albans (UK): National Pharmacy Association, 2005. Available from URL: http://www.npa.co.uk/publications/pressreleases/2005/mar10.html [Accessed 2006 Feb 21]

    Google Scholar 

  32. Policy Development Unit. Prescription charges: should they be abolished? [online] London (UK): Royal Pharmaceutical Society of Great Britain, 2005. Available from URL: http://www.rpsgb.org.uk/pdfs/prescriptcharges.pdf [Accessed 2006 Feb 21]

    Google Scholar 

  33. Scottish Parliament. Health Committee report SP paper 482, 1st report, 2006 (session 2): Abolition of NHS Prescription Charges (Scotland) Bill, 2006 [online]. Available from URL: http://www.scottish.parliamentuk/business/committees/health/reports-06/her06-01-00.htm [Accessed 2006 Mar 14]

  34. Scottish Executive. Review of NHS prescription charges and exemption arrangements in Scotland: consultation. January 2006 [online]. Available from URL: http://www.scotland.gov.uk/resource/doc/90909/0021837.pdf [accessed 2006 Mar 14]

  35. Health Committee. New inquiry — co-payments and charges in the NHS [online]. London (UK): United Kingdom Parliament, 2005. Available from URL: http://www.parliament.uk/parliamentary_committees/health_committee/051013a.cfm [Accessed 2006 Feb 21]

    Google Scholar 

  36. World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva (Switzerland): World Health Organization, 1992

    Google Scholar 

  37. Department of Health. National service framework for mental health: modern standards and service models. London (UK): Department of Health, 1999

    Google Scholar 

  38. Lacro JP. Schizophrenia. In: Koda-Kimble MA, Young LY, Kradjan WA, et al., editors. Applied therapeutics: the clinical use of drugs. 8th ed. Baltimore (MD): Lippincott Williams & Wilkins, 2005

    Google Scholar 

  39. Finley PR, Laird LK, Benefield Jr WH. Mood disorders I: major depressive disorders. In: Koda-Kimble MA, Young LY, Kradjan WA, et al., editors. Applied therapeutics: the clinical use of drugs. 8th ed. Baltimore (MD): Lippincott Williams & Wilkins, 2005

    Google Scholar 

  40. Knapp M, King D, Pugner K, et al. Non-adherence to antipsychotic medication regimens: associations with resource use and costs. Br J Psychiatry 2004; 184: 509–16

    Article  PubMed  Google Scholar 

  41. Eaddy M, Grogg A, Locklear J. Assessment of compliance with antipsychotic treatment and resource utilization in a Medicaid population. Clin Ther 2005; 27: 263–72

    Article  PubMed  Google Scholar 

  42. Soumerai SB, McLaughlin TJ, Ross-Degnan D, et al. Effect of limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. N Engl J Med 1994; 331: 650–5

    Article  PubMed  CAS  Google Scholar 

  43. Sainsbury Centre for Mental Health. Policy paper 3: the economic and social costs of mental illness in England. London (UK): Sainsbury Centre for Mental Health, 2003

    Google Scholar 

  44. DiMatteo MR. Variations in patients’ adherence to medical recommendations. Med Care 2004; 42: 200–9

    Article  PubMed  Google Scholar 

  45. Adams AS, Soumerai SB, Ross-Degnan D. The case for a Medicare drug coverage benefit: a critical review of the empirical evidence. Annu Rev Public Health 2001; 22: 49–61

    Article  PubMed  CAS  Google Scholar 

  46. Schafheutle EI, Cantrill JA, Nicolson M, et al. Insights into the choice between self-medication and a doctor’s prescription: a study of hay fever sufferers. Int J Pharm Pract 1996; 4: 156–61

    Article  Google Scholar 

  47. Payne K, Ryan-Woolley BM, Noyce PR. Role of consumer attributes in predicting the impact of medicines deregulation on National Health Service prescribing in the United Kingdom. Int J Pharm Pract 1998; 6: 150–8

    Article  Google Scholar 

  48. Andalo D. Why the government accepts the hit and miss nature of prescription charges. Pharmaceutical J 2002; 268: 833–4

    Google Scholar 

  49. Department of Trade and Industry. National minimum wage [online]. London (UK): Department of Trade and Industry, 2005. Available from URL: http://www.dti.gov.uk/er/nmw/index.htm [Accessed 2006 Feb 21]

    Google Scholar 

  50. Wanless D. Securing our future health: taking a long-term view. Final report. London (UK): HM Treasury, 2002. Available from URL: http://www.hmtreasury.gov.uk/Consultations_and_Legislation/wanless/consult_wanless_final.cfm [Accessed 2006 Feb 21]

    Google Scholar 

  51. Health and Social Care Information Centre. Prescriptions dispensed in the community: statistics for 1994 to 2004 — England. London (UK): Department of Health, 2005

    Google Scholar 

  52. United Kingdom Parliament. Commons Hansard (2004 Nov 9): prescription charges [online]. London (UK): United Kingdom Parliament, 2005. Available from URL: http://www.publications.parliament.uk/pa/cm200304/cmhansrd/vo041109/text/41109w26.htm [Accessed 2006 Feb 21]

    Google Scholar 

  53. Financial concerns over abolishing prescription charges. Pharmaceutical J 2005; 275: 679

Download references

Acknowledgments

The author is grateful for the support of the Health Foundation (London, UK) and the NHS R&D Programme (London, UK) for funding her National Primary Care Post Doctoral Award.

Author information

Authors and Affiliations

  1. School of Pharmacy and Pharmaceutical Sciences, The University of Manchester, Oxford Road, Manchester, M13 9PL, UK

    Ellen I. Schafheutle Post Doctoral Award (Research Fellow and Pharmacist)

Authors
  1. Ellen I. Schafheutle Post Doctoral Award
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ellen I. Schafheutle Post Doctoral Award.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schafheutle, E.I. Removing Prescription Charges for Patients with Mental Health Disorders. Dis-Manage-Health-Outcomes 14, 139–145 (2006). https://doi.org/10.2165/00115677-200614030-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00115677-200614030-00002

Keywords

Search

Navigation